Batm Advanced Communicat... Share Discussion Threads

[resistance1] 24/7/2024 10:25

British PE invests in StorMagic that offers a solution very similar to Edgility. Interesting to note the point about Broadcom and huge price rises. Telco pushes the cost saving aspect at the moment.

A Bristol-headquartered international edge computing provider has received a significant investment from private equity firm Palatine's Growth Credit Fund.

The business enables organisations of all types and sizes to store, protect, and manage their data at and from the edge. Recently, StorMagic introduced SvHCI, a full-stack software service that can save customers significant costs over VMware and Microsoft.

It marks the first transaction Palatine Growth Credit Fund has completed from its maiden fund.

Palatine believes StorMagic is well-suited to capitalise on new market conditions and the fund has invested in StorMagic aiming to accelerate its growth.

StorMagic, founded in 2006, hahas offices in the USA and Canada.

Will Chappell, head of growth credit, said: "We are thrilled to have reached the successful final close of the Growth Credit Fund and to now be supporting those UK regions which have been historically underserved in this asset class.

"StorMagic is a fantastic business with a meaningful USP and an impressive international client base. Having followed the business’ growth closely for some time, we are excited to welcome a best-in-class edge computing provider to the Fund at a time when innovative, secure and fast connectivity is becoming a business-critical factor for many organisations."

Dan Beer, chief executive at StorMagic, said: "StorMagic is thrilled to have Palatine’s support as the company recently entered a new market segment with the introduction of SvHCI.

"Since Broadcom’s acquisition of VMware, edge and SMB customers have seen massive price increases and many are looking for alternative solutions to help them run on-site applications reliably while reducing costs. SvHCI is the ideal replacement solution and can save SMBs and edge customers up to 62 per cent over VMware alternatives."

[wizzkid211] 24/7/2024 07:00

FSE
I think its a wise move, WIZ will have sales of one billion $ soon and be worth double what google offered.

[kooba] 23/7/2024 21:51

Maybe some other competitors in here?https://www.prnewswire.co.uk/news-releases/molecular-diagnostics-market-worth-32-7-billion-by-2029-driven-by-increasing-technological-advancements--marketsandmarkets-302203749.htmlThanks for your thoughts r1..agree on the potential and relative simplicity and mobility...difficult to know where the rest of the market is relative and when and how they bring it to market.Absolute peanuts to someone like Roche buying on many multiples of funds raised , either to exploit the IP or just remove it from market !Hope we get more details on commercialisation route sooner rather than later.

[resistance1] 23/7/2024 12:27

As far as I understand it Natlab has some great USP's. It can be used onsite at the point of need rather than in a far away lab, saving time and money. Provides results in one 'hit' for a range of likely relation diseases rather than the existing method of testing for one potential virus, then another, then another etc. It does this in 45-mins rather than days -- life saving for some conditions like meningitis. The operational cost of Natlab is lower than any known competitor as shown in the 2023 or 2024 BATM investor presentation with examples provided (cant remember which year.) You need less skilled staff to use the equipment, as it is highly automated. It all seems genuinely groundbreaking unless there are other 'me-too' solutions from competitors other than Oxford Nanopore.

[resistance1] 23/7/2024 12:14

If the new medical device is deemed not to be substantially equivalent to another, it must undergo clinical testing and pre-market approval before it can be marketed unless it is reclassified into a lower regulatory class.

[kooba] 23/7/2024 10:59

Interesting so whilst there are future trials in Q4 2024 they say that NATlab is. Commercial Ready• Prepared for production• More syndromic panels to be added• More patents to be registeredSo it would seem possible that there is the chance of commercial adoption before the results of further trials. It does not seem to explain what the trials are for or what the criteria of performance these trials are set to prove.

[resistance1] 23/7/2024 09:48

Sent via private message

[resistance1] 23/7/2024 08:38

I follow Ador on LinkedIn they do a post every month or so. You are right though any start-up looking to be bought out or attract a major partner to commercialise their offering would be reporting every titbit over socials. In fairness the London conference (the presentation deck I will share)was for pharma/medical outfits to meet potential sector investment partners.

[kooba] 22/7/2024 20:01

Thx ..i thought we were looking at commercial product end of this year which would mean confirmation of efficacy in all the trials must be soon. A lot of money has now gone into a diagnostic product that seems to have missed commercial timelines given by BATM to shareholders ..the company itself ADOR never says anything at all ..no social media nothing ..same as with other BATM companies you wouldn't know they really exist accept Batm comment and a website. Nothing in terms of their place in the industry for what are important and large markets. Edgility tweets but mostly industry stuff on the markets it would like to address...Celare and ADOR and ADALTIS virtually nothing ..and then there is the smaller stuff. Most individuals have a bigger social media presence than many of these companies...weird.

[resistance1] 22/7/2024 19:21

I will see if I can dig out the Ador presentation in London from April and post

[resistance1] 22/7/2024 19:18

The Natlab timings I recall in the last 12 months have said the 2 remaining trials (of 3 trials in total) complete end of the year. Commercial product ready early next year — however long official sanction takes post trials.

[kooba] 22/7/2024 13:02

Virus watch...India alert after boy dies from Nipah virus in Kerala https://www.bbc.com/news/articles/cj50d7e9vp6oSeems a lot of need for good molecular diagnostic products out there!"ADOR Diagnostics progressed development of disruptive NATlab molecular diagnostics platform, with in-hospital pre-clinical trials commencing during the year, and secured $7.5m investment. "Finals MarchI can find virtually nothing on the company since then..were they meant to have a commercial product this year? The goal post there have moved a lot !

[wizzkid211] 18/7/2024 07:20

RESIST,
There are a few big shots eyeing BATM the dam will burst soon

[resistance1] 17/7/2024 20:12

Yes FSE BATM still feels under the radar due to its mixed, and some might say confused portfolio. We now need an Edgility colab or acquisition asap to fix this as Cyber has been on the commercial side. The icing on the cake will be a Natlab/Ador deal once trials have been completed at year end. frustrating that we have to wait for a lift off, but the dam must burst soon … upward.

[resistance1] 17/7/2024 20:06

Small caps are tipped to rise with falling interest rates. Many have significant loans (unlike BATM)and the interest payments will decrease.

[fse] 17/7/2024 16:30

The take out of this is that there is very significant demand and push from new cyber platforms and Edge solutions/platforms. It's also apparent that the revenue from this is only starting to trickle in. Some of these companies are on hefty valuations without the sales hitting the bottom line for a couple of years. BATM is the outlier in this respect as investors are ignoring the potential and valuing the company on straight sales.

[kooba] 17/7/2024 16:27

Is The Surge In Small Caps Only Just Startinghttps://x.com/zerohedge/status/1813596052047434095?s=61&t=s79RLRddG_Gfl7VpUZvZpQ

[kooba] 16/7/2024 10:51

https://x.com/batmltd/status/1813139066252034153?s=61&t=s79RLRddG_Gfl7VpUZvZpQ"Our vision at #BATM is to be leaders in high-technology innovations that make a significant difference to the human experience and build on our values."Maybe that vision can extend to providing a discernible increase in the value of the company giving shareholders a return for decades of investment. Just saying.Try build value for our shareholders at the end..reads far better!

[wizzkid211] 16/7/2024 06:30

A few months ago, Wiz predicted that this year would be a year of more massive transition to cloud services in cybersecurity

[wizzkid211] 16/7/2024 06:27

Report: Google in advanced talks to acquire Israeli Wiz for $23 billion
The Wall Street Journal reports that Google is close to closing its largest ever deal with Wiz – which, if implemented, would also be the largest deal in the history of Israeli high-tech. It is estimated that each of the four founders of the cyber company is expected to earn over $2 billion from the acquisition

[kemche] 15/7/2024 17:33

Back to treeshaking I see.